Results 221 to 230 of about 1,943,814 (363)
Inhibition of RNA polymerase and formyltetrahydrofolate synthetase activity by 6‐chloro‐8‐aza‐9‐cyclopentylpurine. Structure‐activity relationships [PDF]
Raymond W. Ruddon+2 more
openalex +1 more source
Compound Heterozygous MRPS14 Variants Associated With Leigh Syndrome
ABSTRACT MRPS14 (uS14m) is a nuclear‐encoded ribosomal protein important for mitochondria‐specific translation. To date, only a single individual with a recessive MRPS14‐related disorder (also known as COXPD38) has been reported. We report an additional subject possessing novel compound heterozygous MRPS14 variants (p.Asp37Asn, p.Asn60Asp). The subject
Maria Gabriela Otero+15 more
wiley +1 more source
IPANEMAP Suite: a pipeline for probing-informed RNA structure modeling. [PDF]
Hardouin P+6 more
europepmc +1 more source
Observation of coordinated RNA folding events by systematic cotranscriptional RNA structure probing. [PDF]
Szyjka CE, Strobel EJ.
europepmc +1 more source
DNA-dependent RNA polymerases from Artemia salina. Subunit structure of polymerase II [PDF]
J.C. Bagshaw
openalex +1 more source
Hypoxia promotes the epithelial‐mesenchymal transition (EMT) of renal tubular epithelial cells via the SIRT1‐FoxO1‐FoxO3‐autophagy pathway, thereby resulting in the fibrosis of renal tubular epithelial cells. Activation of SIRT1 or induction of autophagy inhibits this process, alleviating hypoxia‐induced fibrosis.
Guangyu Wang+6 more
wiley +1 more source
Bioorthogonal Cyclopropenones for Investigating RNA Structure. [PDF]
Chen S+7 more
europepmc +1 more source
Secondary Structure of the 5′ End of Bacteriophage MS2 RNA [PDF]
D. Iserentant, Walter Fiers
openalex +1 more source
Extracellular vesicles (EVs) play a dual role in diagnostics and therapeutics, offering innovative solutions for treating cancer, cardiovascular, neurodegenerative, and orthopedic diseases. This review highlights EVs’ potential to revolutionize personalized medicine through specific applications in disease detection and treatment.
Farbod Ebrahimi+4 more
wiley +1 more source